AzTrials
AzTrials

Dental Implant FailedNCT03741036

Immediate Implant Placement With Provisionalization Using Different Bone Grafts as a Space Filling Material in the Maxillary Esthetic Zone

A study testing Autogenous bone graft as space filling in immidiate implant placment, Deprotinized bovien as space filling in immidate implant placement and Nano-hydroxiapatite alloplast in immidiate implant placement in people with Dental Implant Failed, run by Mohamed tarek mohamed youssif omar at 2 sites in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

compare autogenous bone graft, xenograft and nanohydroxyapatite in immediate implant w placement in maxillary esthetic zone with provisionalization Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Dental Implant Failed
What is being tested?
Autogenous bone graft as space filling in immidiate implant placment, Deprotinized bovien as space filling in immidate implant placement and Nano-hydroxiapatite alloplast in immidiate implant placement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
2 sitesEgypt
Study dates
27 Nov 2018to 17 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adult patients with badly broken teeth in upper esthetic zone indicated for extraction
  • Both sexes.
  • No intraoral soft and hard tissue pathology
  • No systemic condition that contraindicate implant placemen

Who cannot join

  • Heavy smokers more than 20 cigarettes per day.
  • Patients with systemic disease that may affect normal healing.
  • Psychiatric problems
  • Disorders to implant are related to history of radiation therapy to the head and neck neoplasia

Trial locations and contacts

2 sites in 1 country.

mohamed tarek, master contact

01114951862

mtm.omar@yahoo.com

Egypt2 sites
  • Cairo University

    Cairo

  • Mohamed tarek

    Cairo

    Mohamed Tarek, 00201114951862, Mtm.9mar@yahoo.com

Other trials in Egypt

About this study

Official title: Immediate Implant Placement With Provisionalization Using Autogenous Bone Graft Particulates vs Deproteinized Bovine Bone vs Nano-hydroxyapatite Alloplast as a Space Filling Material in the Maxillary Esthetic Zone

compare autogenous bone graft, xenograft and nanohydroxyapatite in immediate implant w placement in maxillary esthetic zone with provisionalization

Read the detailed description

Placement of implants into extraction sockets targets the maintenance of peri implant hard and soft tissue structures and the support of a natural and esthetic contour. The main advantages of immediate implant insertion in comparison with delayed implant placement protocols are as follows: a reduced treatment time, less number of sessions, and, thus, the less invasive procedure. This study examines the clinical performance (survival rate, marginal bone levels and Pink Esthetic Score [PES]) of OsseoSpeed™ implants placed into extraction sockets with immediate provisionalization in the anterior maxilla after a follow-up of at least 12 months.

The removal of teeth results inevitably in both horizontal and vertical changes of hard and soft tissue dimensions.

Clinical research has shown that the loss of volume in the extraction sockets is high: the biggest bone volumetric changes take place during the first 12 months from the dental extraction, with a reduction of bone volume of 50%, of which 2/3 (30%) are within the first 3 months.

Nowadays to get success in postextraction implantology means managing the early and irreversible alveolar bone dimensional changes following tooth extraction, in order to minimize the negative effects on the aesthetics final.

Being tested
Autogenous bone graft as space filling in immidiate implant placment, Deprotinized bovien as space filling in immidate implant placement, Nano-hydroxiapatite alloplast in immidiate implant placement
Keywords
immidiate, dental implant, immidiate provisionalization, bone graft

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Autogenous bone graft as space filling in immidiate implant placmentProcedure or surgery

    • The selected patients will be informed of the nature of the research work and informed consent will be obtained (immediate implant placement grafting with autogenous bone graft)
    • Patients will be subjected to CBCT (diagnostic for upper arch).
    • Local anesthesia will be given to the patient.
    • Scrubbing and draping of the patient will be carried out in a standard fashion for intra oral procedures.
    • The procedure will be carried out flapless.
    • In the study group: Atraumatic extraction
    • The extraction socket will be evaluated for absence of any fenestration or granulation tissues
  • Deprotinized bovien as space filling in immidate implant placementProcedure or surgery

    • The selected patients will be informed of the nature of the research work and informed consent will be obtained (immediate implant placement grafting with deprotinized bovien material)
    • Patients will be subjected to CBCT (diagnostic for upper arch).
    • Local anesthesia will be given to the patient.
    • Scrubbing and draping of the patient will be carried out in a standard fashion for intra oral procedures.
    • The procedure will be carried out flapless.
    • In the study group: Atraumatic extraction
    • The extraction socket will be evaluated for absence of any fenestration or granulation tissues
  • Nano-hydroxiapatite alloplast in immidiate implant placementProcedure or surgery

    • The selected patients will be informed of the nature of the research work and informed consent will be obtained (immediate implant placement grafting with nano-hydroxiapatite alloplast material )
    • Patients will be subjected to CBCT (diagnostic for upper arch).
    • Local anesthesia will be given to the patient.
    • Scrubbing and draping of the patient will be carried out in a standard fashion for intra oral procedures.
    • The procedure will be carried out flapless.
    • In the study group: Atraumatic extraction
    • The extraction socket will be evaluated for absence of any fenestration or granulation tissues
Study groups in NCT03741036
Study groupRoleWhat they receive
autogenous bone graft as a space filling materialActive comparatorAutogenous bone from sub mental bone had been grafted in jumping gap between implant and freshely extracted socket
Receives: Procedure: Autogenous bone graft as space filling in immidiate implant placment
deproteinized bovine as a space filling materialActive comparatorGranules of deproteinized bovine bone of 0.25-1.0 mm diameter were used to fill the remaining defect when the distance of the defect wall to the implant surface was > 3 mm.
Receives: Procedure: Deprotinized bovien as space filling in immidate implant placement
nano-hydroxyapatite alloplast as a space filling materialActive comparatorThe patient was treated using alloplast material mixed with a nano-bone graft to fill gap between implant and freshely extracted socket
Receives: Procedure: Nano-hydroxiapatite alloplast in immidiate implant placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary stability (marginal bone loss)

    measure device (osstell )

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2018
  2. Study start27 Nov 2018 (estimated)
  3. Primary completion27 Jul 2019 (estimated)
  4. Study completion17 Aug 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03741036
Sponsor's protocol ID
CEBD-CU-27-7-2018
Status last verified
Nov 2018
First submitted
19 Oct 2018
Last updated
19 Nov 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Autogenous bone graft as space filling in immidiate implant placment, Deprotinized bovien as space filling in immidate implant placement and Nano-hydroxiapatite alloplast in immidiate implant placement in people with Dental Implant Failed, run by Mohamed tarek mohamed youssif omar at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Nov 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact mohamed tarek, master (01114951862, mtm.omar@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Primary stability (marginal bone loss) (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2018; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in